TMCITreace Medical Concepts Inc
TMCI
Treace Medical Concepts Inc342
Mkt Cap
$118.52MVolume
1.29M52W High
$9.5652W Low
$1.81PE Ratio
-2.34TMCI Fundamentals
Price
$1.86Prev Close
$2.10Open
$2.1450D MA
$2.37Beta
1.21Avg. Volume
640,180.35EPS (Annual)
-$0.9326P/B
1.33Rev/Employee
$472,644.44$178.50
Poll
Earnings Recap
• Reported GAAP EPS of -$0.15 down -1400.00% YoY • Reported revenue of $62.52M down -9.01% YoY • Treace Medical Concepts Inc. forecasts full-year 2026 revenue of $200M to $212M, a 6% to 0% decline from 2025. The company also expects a full-year 2026 Adjusted EBITDA loss between $4M and $6M.
Bullish
Treace Medical Concepts Inc. increased active surgeons by 6% and reduced cash usage by 46% in 2025. The company also expanded its patent portfolio and expects market share gains and restored topline growth in 2026.
Bearish
Q4 revenue declined 9% due to a shift to lower-priced kits, leading to a -$9.4M net loss. Treace Medical Concepts Inc. also forecasts a 6% to 0% revenue decline and an increased Adjusted EBITDA loss for full-year 2026.